Regeneron Pharmaceuticals, Inc. (REGN)

754.20 -1.31 (-0.17%) USD  |  NASDAQ  |  Jan 23, 14:42
More

Regeneron Pharmaceuticals Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade